Biotech · Private company
Suzhou Kintor Pharmaceutical Inc,
Track this companyFree. Adds Suzhou Kintor Pharmaceutical Inc, to your Dealase workspace and tells you when its record changes.
Clinical trials90 recruiting or active
Pipeline programs9From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline9
- GT0918Phase 3 · Covid19ClinicalTrials.gov · fetched Nov 12, 2026
- Proxalutamide (GT0918)Phase 3 · Efficacy and SafetyClinicalTrials.gov · fetched Nov 12, 2026
- GT0918Phase 2 · Metastatic Castrate Resistant Prostate Cancer (mCRPC)ClinicalTrials.gov · fetched Nov 12, 2026
- GT90001Phase 2 · Hepatocellular CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- KX- 826 dosed at 2.5mgPhase 2 · AlopeciaClinicalTrials.gov · fetched Nov 12, 2026
- KX-826 dosed at 5mgPhase 2 · AlopeciaClinicalTrials.gov · fetched Nov 12, 2026
- NivolumabPhase 2 · Hepatocellular CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- GT20029 GelPhase 1 · Androgenetic AlopeciaClinicalTrials.gov · fetched Nov 12, 2026
- KX0826Phase 1 · Androgenetic AlopeciaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials9
- Study in Subjects to Evaluate the Safety, Tolerability and Pharmacokinetics of GT20029PHASE1 · COMPLETED · started Feb 10, 2022ClinicalTrials.gov NCT05428449 · fetched Nov 12, 2026
- To Evaluate Efficacy, Safety, and Tolerability of KX-826 in Male Subjects With Androgenetic AlopeciaPHASE2 · COMPLETED · started Jan 31, 2022ClinicalTrials.gov NCT05218642 · fetched Nov 12, 2026
- A Study to Evaluate the Efficacy and Safety of Proxalutamide (GT0918) in Hospitalized COVID-19 SubjectsPHASE3 · TERMINATED · started Sep 30, 2021ClinicalTrials.gov NCT05009732 · fetched Nov 12, 2026
- GT90001 Plus Nivolumab in Patients With Advanced Hepatocellular CarcinomaPHASE2 · UNKNOWN · started Aug 1, 2021ClinicalTrials.gov NCT05178043 · fetched Nov 12, 2026
- Proxalutamide (GT0918) Treatment for Outpatients With Mild or Moderate COVID-19 IllnessPHASE3 · COMPLETED · started Mar 5, 2021ClinicalTrials.gov NCT04870606 · fetched Nov 12, 2026
- the Safety, Tolerability and PK of KX-826 in Healthy Males With Alopecia Following Topical Multiple Dose AscendingPHASE1 · COMPLETED · started Jan 14, 2020ClinicalTrials.gov NCT04502901 · fetched Nov 12, 2026
- The Safety and Tolerability of GT0918 in Subjects With mHSPC and mCRPCPHASE2 · COMPLETED · started May 30, 2019ClinicalTrials.gov NCT03899467 · fetched Nov 12, 2026
- Safety, Tolerability and Pharmacokinetics of KX826 in Healthy Male Subjects With Androgenetic Alopecia Following Topical Single Ascending Dose AdministrationPHASE1 · COMPLETED · started Jan 28, 2019ClinicalTrials.gov NCT04984707 · fetched Nov 12, 2026
- Safety, Tolerability, and PK of GT0918 (Proxalutamide) in Subjects With Metastatic Castrate Prostate CancerPHASE1 · COMPLETED · started Feb 10, 2016ClinicalTrials.gov NCT02826772 · fetched Nov 12, 2026